Injection of mesenchymal stromal cells into a mechanically stimulated in vitro model of cardiac fibrosis has paracrine effects on resident fibroblasts

Cytotherapy

Volumn 16, Issue 7, 2014, Pages 906-914

  Galie, Peter A ^a   Stegemann, Jan P ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cardiac fibrosis; Cell therapy; Co culture; Hypoxia; Mesenchymal stromal cells

Indexed keywords

SOMATOMEDIN C; VASCULOTROPIN; OXYGEN; SOMATOMEDIN; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID FLOW; GENE EXPRESSION; HEART MUSCLE FIBROSIS; HYPOXIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; INJECTION; INTERSTITIAL FLUID; MECHANICAL STRESS; MESENCHYMAL STROMA CELL; MYOFIBROBLAST; NONHUMAN; OXYGEN TENSION; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; CELL HYPOXIA; CYTOLOGY; FIBROSIS; GENETICS; HEART INFARCTION; HUMAN; METABOLISM; PATHOLOGY; SCAR;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; CICATRIX; COCULTURE TECHNIQUES; FIBROSIS; HUMANS; IN VITRO TECHNIQUES; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOFIBROBLASTS; OXYGEN; PARACRINE COMMUNICATION; RATS; SOMATOMEDINS; STRESS, MECHANICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901975624     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.01.416     Document Type: Article

References (33)

1. Elnakish M.T., Kuppusamy P., Khan M. Stem cell transplantation as a therapy for cardiac fibrosis. JPathol 2013, 229:347-354.
2. Duran J.M., Taghavi S., George J.C. The need for standardized protocols for future clinical trials of cell therapy. Transl Res 2012, 160:399-410.
3. Perin E.C., Silva G.V., Henry T.D., Cabreira-Hansen M.G., Moore W.H., Coulter S.A., et al. Arandomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 2011, 161:1078-1087.
4. Jaquet K., Krause K.T., Denschel J., Faessler P., Nauerz M., Geidel S., et al. Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism?. Stem Cells Dev 2005, 14:299-309.
5. Fang J., Chen L., Fan L., Wu L., Chen X., Li W., et al. Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats. JMol Cell Cardiol 2011, 5:839-847.
6. Boudoulas K.D., Hatzopoulos A.K. Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech 2009, 2:344-358.
7. Galie P.A., Stegemann J.P. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices. Cardiovasc Pathol 2011, 20:325-333.
8. Trivedi P., Tray N., Nguyen T., Nigam N., Gallicano G.I. Mesenchymal stem cell therapy for treatment of cardiovascular disease: helping people sooner or later. Stem Cells Dev 2010, 19:1109-1120.
9. Xu W., Zhang X., Qian H., Zhu W., Sun X., Hu J., et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004, 229:623-631.
10. Nygren J., Jovinge S., Breitbach M., Säwén P., Röll W., Hescheler J., et al. Bone-marrow derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004, 10:494-501.
11. Siegel G., Krause P., Wöhrle S., Nowak P., Ayturan M., Kluba T., et al. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells Dev 2012, 21:2457-2470.
12. Mias C., Lairez O., Trouche E., Roncalli J., Calise D., Seguelas M.H., et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009, 27:2734-2743.
13. Ohnishi S., Sumiyoshi H., Kitamura S., Nagaya N. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett 2007, 581:3961-3966.
14. Timmers L., Lim S.K., Hoefer I.E., Arslan F., Lai R.C., van Oorschot A.A., et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 2011, 6:206-214.
15. Koninckx R., Hensen K., Daniëls A., Moreels M., Lambrichts I., Jongen H., et al. Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy 2009, 11:778-792.
16. Zhou Y., Wang S., Yu Z., Hoyt R.F., Sachdev V., Vincent P., et al. Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Commun 2009, 390:902-907.
17. Beeres S.L., Bax J.J., Dibbets P., Stokkel M.P., Zeppenfeld K., Fibbe W.E., et al. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. JNucl Med 2006, 47:574-580.
18. Poynter J.A., Herrmann J.L., Manukyan M.C., Wang Y., Abarbanell A.M., Weil B.R., et al. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism. JAm Coll Surgeons 2011, 213:253-260.
19. Du Y.Y., Yao R., Pu S., Zhao X.Y., Liu G.H., Zhao L.S., et al. Mesenchymal stem cells implantation increases the myofibroblasts congregating in infarct region in a rat model of myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 2012, 40:1045-1050.
20. Wright E.J., Farrell K.A., Malik N., Kassem M., Lewis A.L., Wallrapp C., et al. Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts. Stem Cells Transl Med 2012, 1:759-769.
21. Fan B.S., Lou J.Y. Enhancement of angiogenic effect of co-transfection human NGF and VEGF genes in rat bone marrow mesenchymal stem cells. Gene 2011, 485:167-171.
22. Gnecchi M., He H., Melo L.G., Noiseaux N., Morello F., de Boer R.A., et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009, 27:971-979.
23. Huang W., Wang T., Zhang D., Zhao T., Dai B., Ashraf A., et al. Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. Stem Cells Dev 2012, 21:778-789.
24. Zuo S., Jones W.K., Li H., He Z., Pasha Z., Yang Y., et al. Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. Stem Cells Dev 2012, 21:598-608.
25. Cummings C.L., Gawlitta D., Nerem R.M., Stegemann J.P. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 2004, 25:3699-3706.
26. Rowe S.L., Stegemann J.P. Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios. Biomacromolecules 2006, 7:2942-2948.
27. Rowe S.L., Stegemann J.P. Microstructure and mechanics of collagen-fibrin matrices polymerized using ancrod snake venom enzyme. JBiomech Eng 2009, 131:061012.
28. Galie P.A., Stegemann J.P. Simultaneous application of interstitial flow and cyclic mechanical strain to a three-dimensional cell-seeded hydrogel. Tissue Eng Part C Methods 2011, 17:527-536.
29. Wang J., Chen H., Seth A., McCulloch C.A. Mechanical forceregulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2003, 285:H1871-H1881.
30. MacKenna D.A., Dolfi F., Vuori K., Ruoslahti E. Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. JClin Invest 1998, 101:301-310.
31. Galie P.A., Spilker R.L., Stegemann J.P. Alinear, biphasic model incorporating a brinkman term to describe the mechanics of cell-seeded collagen hydrogels. Ann Biomed Eng 2011, 39:2767-2779.
32. Galie P.A., Russell M.W., Westfall M.V., Stegemann J.P. Interstitial fluid flow and cyclic strain differentially regulate cardiac fibroblast activation via AT1R and TGF-β1. Exp Cell Res 2012, 318:75-84.
33. Cerrada I., Ruiz-Saurí A., Carrero R., Trigueros C., Dorronsoro A., Sanchez-Puelles J.M., et al. Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair. Stem Cells Dev 2013, 22:501-511.